Products
-
- BBB DamageCell Death and ApoptosisNeuroinflammationNeuronal Damage and RepairOxidative StressVascular Mechanisms
- 3D BBB Models
- Organ-on-a-Chip BBB ModelsTranswell Models3D BBB Models Culture Substrate
- 3D HydrogelsCollagensAnmial BBB ModelsCell Lines for BBB Modeling
- Immortalized CellsPrimary CellsStem Cells
Recombinant Human c-Kit Protein (6×His Tag) (AC1106)
Cat.#: ACPP-1106
Specifications
Despition Recombinant Human c-Kit Protein (6×His Tag) for ELISA, SDS-PAGE SIZE 50 µg Source Recombinant Protein Length Fragment Expression System HEK293 cells Protein Species Human Sequence CD117 (Gln26-Thr520) + 6×His Tag Molecular Weight 56.5 kDa without signal peptide Purity > 95% by SDS-PAGE and Coomassie blue staining. Form Lyophilized Tag C-terminal 6×His Tag Applications ELISA, SDS-PAGE Storage Lyophilized was stored at -20°C to -80°C, while reconstituted was aliquot and stored at -80°C. Avoid freeze/thaw cycles. Shipping Shipped at 4°C Citation Guidance If you use our product in a scientific publication, please cite it as "Ace Therapeutics Cat.#". Click here to submit your paper's PubMed ID (PMID) to receive rewards. Related Products
Cat.# Name Size Price ACPP-1780 Human DYRK1A Protein (AC1780) 5 µg inquiry ACPP-1078 Glutamate Receptor 1 Blocking Peptide (AC1078) 250 µg inquiry ACPP-1298 Syndecan-1 Blocking Peptide (AC1298) 250 µg inquiry ACPP-1245 CRMP2 Blocking Peptide (AC1245) 250 µg inquiry ACPP-1738 Human PNOC Protein (AC1738) 5 µg inquiry ACPP-1165 Recombinant Mouse PGRPS Protein (Fc Tag) (AC1165) 50 µg inquiry ACPP-1397 Human RNLS Protein (AC1397) 5 µg inquiry ACPP-1541 Human OTOR Protein (AC1541) 5 µg inquiry ACPP-1081 Human NRN1 Protein (AC1081) 5 µg inquiry ACPP-1173 Recombinant Human alpha Synuclein Protein (AC1173) 50 µl inquiry All of our products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.
0Inquiry Basket